Thought Leadership

Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Expanding and Serving the Market with Flexible Single-Use Capacity

Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status

Unique Commercial Experience Primes Avid Bioservices for Growth

Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience

ADC Therapeutics Taps Avid for Production of it's New Blood Cancer Med Zynlota

Making the Switch to Single-Use Technologies

Large Molecule Manufacturing May Be Turning To Local Markets

Case Study for a Facility-Fit Driven Process Development